BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2649849)

  • 1. The binding of guanine nucleotide to N-ras p21--a phosphorous and proton magnetic resonance study.
    Grand RJ; Levine BA; Byrd PJ; Gallimore PH
    Oncogene; 1989 Mar; 4(3):355-61. PubMed ID: 2649849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of the guanine nucleotide exchange reaction of Ras GTPase--evidence for a GTP/GDP displacement model.
    Zhang B; Zhang Y; Shacter E; Zheng Y
    Biochemistry; 2005 Feb; 44(7):2566-76. PubMed ID: 15709769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-dependent perturbation of Ras-guanine nucleotide interactions and Ras guanine nucleotide exchange.
    Heo J; Gao G; Campbell SL
    Biochemistry; 2004 Aug; 43(31):10102-11. PubMed ID: 15287738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency (139.5 GHz) electron paramagnetic resonance characterization of Mn(II)-H2(17)O interactions in GDP and GTP forms of p21 ras.
    Bellew BF; Halkides CJ; Gerfen GJ; Griffin RG; Singel DJ
    Biochemistry; 1996 Sep; 35(37):12186-93. PubMed ID: 8810926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional analysis of a mutant Ras protein that is insensitive to nitric oxide activation.
    Mott HR; Carpenter JW; Campbell SL
    Biochemistry; 1997 Mar; 36(12):3640-4. PubMed ID: 9132016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-frequency 94 GHz ENDOR characterization of the metal binding site in wild-type Ras x GDP and its oncogenic mutant G12V in frozen solution.
    Bennati M; Hertel MM; Fritscher J; Prisner TF; Weiden N; Hofweber R; Spörner M; Horn G; Kalbitzer HR
    Biochemistry; 2006 Jan; 45(1):42-50. PubMed ID: 16388579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.
    Moodie SA; Paris M; Villafranca E; Kirshmeier P; Willumsen BM; Wolfman A
    Oncogene; 1995 Aug; 11(3):447-54. PubMed ID: 7630628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational transitions in p21ras and in its complexes with the effector protein Raf-RBD and the GTPase activating protein GAP.
    Geyer M; Schweins T; Herrmann C; Prisner T; Wittinghofer A; Kalbitzer HR
    Biochemistry; 1996 Aug; 35(32):10308-20. PubMed ID: 8756686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of free radical nitric oxide-mediated Ras guanine nucleotide dissociation.
    Heo J; Prutzman KC; Mocanu V; Campbell SL
    J Mol Biol; 2005 Mar; 346(5):1423-40. PubMed ID: 15713491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanine nucleotide binding properties of purified v-Ki-ras p21 protein produced in Escherichia coli.
    Hara M; Tamaoki T; Nakano H
    Oncogene Res; 1988 May; 2(4):325-33. PubMed ID: 3135524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dynamics simulations of Gly-12-->Val mutant of p21(ras): dynamic inhibition mechanism.
    Futatsugi N; Tsuda M
    Biophys J; 2001 Dec; 81(6):3483-8. PubMed ID: 11721009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Backbone dynamics of an oncogenic mutant of Cdc42Hs shows increased flexibility at the nucleotide-binding site.
    Adams PD; Loh AP; Oswald RE
    Biochemistry; 2004 Aug; 43(31):9968-77. PubMed ID: 15287724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and dynamic differences between normal and transforming N-ras gene products: a 31P and isotope-edited 1H NMR study.
    Campbell-Burk S
    Biochemistry; 1989 Nov; 28(24):9478-84. PubMed ID: 2692710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and function of p21 ras proteins.
    Shih TY; Hattori S; Clanton DJ; Ulsh LS; Chen ZQ; Lautenberger JA; Papas TS
    Gene Amplif Anal; 1986; 4():53-72. PubMed ID: 3333361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and biological consequences of changing the specificity of p21ras from guanosine to xanthosine nucleotides.
    Schmidt G; Lenzen C; Simon I; Deuter R; Cool RH; Goody RS; Wittinghofer A
    Oncogene; 1996 Jan; 12(1):87-96. PubMed ID: 8552403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformation of guanosine 5'-diphosphate as bound to a human c-Ha-ras mutant protein: a nuclear Overhauser effect study.
    Ha JM; Ito Y; Kawai G; Miyazawa T; Miura K; Ohtsuka E; Noguchi S; Nishimura S; Yokoyama S
    Biochemistry; 1989 Oct; 28(21):8411-6. PubMed ID: 2690941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic analysis by fluorescence of the interaction between Ras and the catalytic domain of the guanine nucleotide exchange factor Cdc25Mm.
    Lenzen C; Cool RH; Prinz H; Kuhlmann J; Wittinghofer A
    Biochemistry; 1998 May; 37(20):7420-30. PubMed ID: 9585556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic and structural analysis of the Mg(2+)-binding site of the guanine nucleotide-binding protein p21H-ras.
    John J; Rensland H; Schlichting I; Vetter I; Borasio GD; Goody RS; Wittinghofer A
    J Biol Chem; 1993 Jan; 268(2):923-9. PubMed ID: 8419371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and biochemical characterization of the GTPgammaS-, GDP.Pi-, and GDP-bound forms of a GTPase-deficient Gly42 --> Val mutant of Gialpha1.
    Raw AS; Coleman DE; Gilman AG; Sprang SR
    Biochemistry; 1997 Dec; 36(50):15660-9. PubMed ID: 9398294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation.
    Pai EF; Kabsch W; Krengel U; Holmes KC; John J; Wittinghofer A
    Nature; 1989 Sep; 341(6239):209-14. PubMed ID: 2476675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.